The Recall Desk

Manufacturer

Samantha Lynn, Inc

1 recall in our database name Samantha Lynn, Inc as the manufacturing or recalling firm.

What the numbers show

Total
1
Critical
0
Severe
1
Most recent
2012-12-05

Of the 1 recalls from Samantha Lynn, Inc we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 1 (100%) are Severe.

About this listing

The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.

Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.

1–1 of 1

  • SevereFDA (Drugs)·D-063-2013·2012-12-05

    Samantha Lynn Recalls Reumofan Plus Tablets for Undeclared Ingredients

    Samantha Lynn, Inc. is recalling Reumofan Plus Tablets because they contain undeclared drug ingredients, making them unapproved drugs.

    Product
    Reumofan Plus Tablets, 30-count bottle per Box, (remaining label information in Spanish)
    Category
    Drug
    Distribution
    Distributed nationwide